Young and middle-aged adults taking drugs for attention deficit-hyperactivity disorder (ADHD) do not seem to face an increased risk for cardiovascular disease, a new study finds.
Young and middle-aged adults taking drugs for attention deficit-hyperactivity disorder (ADHD) do not seem to face an increased risk for cardiovascular disease, a new study finds.
